Difference between revisions of "Part:BBa K3096017:Design"

m (Source)
m (References)
 
Line 18: Line 18:
  
 
===References===
 
===References===
 +
Teuta Opačak-Bernardi and Jung Su Ryu and Drazen Raucher. Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells. Journal of Drug Targeting. Volume 25. Number 6. pages 523-531. 2017. Taylor & Francis.10.1080/1061186X.2017.1289537

Latest revision as of 12:29, 15 October 2019


SynB1 - cell penetrating peptide


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 46
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

sequence was taken from Opacak-Bernardi.


Source

Teuta Opačak-Bernardi and Jung Su Ryu and Drazen Raucher. Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells. Journal of Drug Targeting. Volume 25. Number 6. pages 523-531. 2017. Taylor & Francis.10.1080/1061186X.2017.1289537

References

Teuta Opačak-Bernardi and Jung Su Ryu and Drazen Raucher. Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells. Journal of Drug Targeting. Volume 25. Number 6. pages 523-531. 2017. Taylor & Francis.10.1080/1061186X.2017.1289537